TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Onconetix ( (ONCO) ) is now available.
On August 28, 2025, Onconetix, Inc. issued promissory notes to Keystone Capital Partners, LLC and its affiliate, KCP Fund I, LLC, with a principal amount of $58,823.53 each, due by May 28, 2026, or earlier upon sufficient proceeds from an equity line of credit. These notes are subordinate to existing debt obligations to Veru Inc. and include provisions for mandatory prepayment under certain conditions. Additionally, the company has been involved in a series of agreements with Veru Inc. regarding the repayment of notes related to a previous asset purchase agreement. The latest amendments increased the principal amount owed and extended the maturity dates, reflecting ongoing negotiations and adjustments to the company’s financial obligations.
Spark’s Take on ONCO Stock
According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.
Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.
To see Spark’s full report on ONCO stock, click here.
More about Onconetix
Average Trading Volume: 672,934
Technical Sentiment Signal: Sell
Current Market Cap: $4.53M
See more insights into ONCO stock on TipRanks’ Stock Analysis page.